UFP Technologies, Inc. Operating Lease, Payments
UFP Technologies, Inc. (UFPT) reported Operating Lease, Payments of $2.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-06
- UFP Technologies, Inc. operating lease, payments for the quarter ending 2026-06-30 was $1.30M, a 12.61% increase year-over-year.
- UFP Technologies, Inc. operating lease, payments for the quarter ending 2026-03-31 was $1.28M, a 18.05% increase year-over-year.
- UFP Technologies, Inc. operating lease, payments for the quarter ending 2025-12-31 was $1.78M, a 68.14% increase year-over-year.
- UFP Technologies, Inc. operating lease, payments for the quarter ending 2025-09-30 was $1.33M, a 27.47% increase year-over-year.
- UFP Technologies, Inc. operating lease, payments for fiscal 2025 was $5.36M, a 41.52% increase from fiscal 2024.
- UFP Technologies, Inc. operating lease, payments for fiscal 2024 was $3.78M, a 27.02% increase from fiscal 2023.
- UFP Technologies, Inc. operating lease, payments for fiscal 2023 was $2.98M, a 21.49% increase from fiscal 2022.
- UFP Technologies, Inc. operating lease, payments for fiscal 2022 was $2.45M, a 90.97% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.59M 10-Q · filed 2026-08-06 | $4.37M derived: sum of 3 quarters · filed 2026-08-06 | $5.70M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-08 | $3.07M derived: sum of 2 quarters · filed 2026-05-08 | $4.39M derived: sum of 3 quarters · filed 2026-05-08 | $5.55M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.11M derived: sum of 2 quarters · filed 2026-02-27 | $4.27M derived: sum of 3 quarters · filed 2026-08-06 | $5.36M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.48M derived: sum of 2 quarters · filed 2026-08-06 | $3.57M 10-Q · filed 2025-11-07 | $4.63M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.24M 10-Q · filed 2026-08-06 | $3.31M derived: sum of 3 quarters · filed 2026-08-06 | $4.35M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-08 | $2.15M derived: sum of 2 quarters · filed 2026-05-08 | $3.19M derived: sum of 3 quarters · filed 2026-05-08 | $4.04M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.10M derived: sum of 2 quarters · filed 2026-02-27 | $2.95M derived: sum of 3 quarters · filed 2026-02-27 | $3.78M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.89M derived: sum of 2 quarters · filed 2025-11-07 | $2.72M 10-Q · filed 2025-11-07 | $3.50M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.68M 10-Q · filed 2025-08-11 | $2.46M derived: sum of 3 quarters · filed 2026-02-27 | $3.25M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $834.00K 10-Q · filed 2025-05-12 | $1.62M derived: sum of 2 quarters · filed 2026-02-27 | $2.41M derived: sum of 3 quarters · filed 2026-02-27 | $3.13M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.57M derived: sum of 2 quarters · filed 2026-02-27 | $2.30M derived: sum of 3 quarters · filed 2026-02-27 | $2.98M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.51M derived: sum of 2 quarters · filed 2024-11-12 | $2.20M 10-Q · filed 2024-11-12 | $2.81M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $724.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.41M 10-Q · filed 2024-08-09 | $2.02M derived: sum of 3 quarters · filed 2024-08-09 | $2.68M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $683.00K 10-Q · filed 2024-05-10 | $1.30M derived: sum of 2 quarters · filed 2024-05-10 | $1.95M derived: sum of 3 quarters · filed 2024-05-10 | $2.60M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.27M derived: sum of 2 quarters · filed 2024-02-29 | $1.91M derived: sum of 3 quarters · filed 2024-02-29 | $2.45M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.30M derived: sum of 2 quarters · filed 2023-11-09 | $1.84M 10-Q · filed 2023-11-09 | $2.21M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.18M 10-Q · filed 2023-08-09 | $1.56M derived: sum of 3 quarters · filed 2023-08-09 | $1.56M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $540.00K 10-Q · filed 2023-05-10 | $915.00K derived: sum of 2 quarters · filed 2023-05-10 | $915.00K derived: sum of 3 quarters · filed 2023-05-10 | $1.52M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $375.00K derived: sum of 2 quarters · filed 2023-03-16 | $979.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.28M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-05 | $604.00K derived: sum of 2 quarters · filed 2022-11-14 | $909.00K 10-Q · filed 2021-11-05 | $1.21M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $604.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-14 | $909.00K 10-Q/A · filed 2022-11-14 | $608.00K 10-Q · filed 2021-08-06 | $1.21M derived: sum of 3 quarters · filed 2022-11-14 | $1.51M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-03-31 | $305.00K 10-Q · filed 2022-05-10 | $609.00K derived: sum of 2 quarters · filed 2022-05-10 | $910.00K derived: sum of 3 quarters · filed 2022-05-10 | $1.21M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $605.00K derived: sum of 2 quarters · filed 2022-03-14 | $907.00K derived: sum of 3 quarters · filed 2022-03-14 | $1.21M 10-K · filed 2022-03-14 | |
| 2020-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $603.00K derived: sum of 2 quarters · filed 2021-11-05 | $908.00K 10-Q · filed 2021-11-05 | $1.21M derived: sum of 4 quarters · filed 2021-11-05 | |
| 2020-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $607.00K 10-Q · filed 2021-08-06 | $910.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.21M derived: sum of 4 quarters · filed 2021-08-06 | |
| 2020-03-31 | $305.00K 10-Q · filed 2021-05-07 | $608.00K derived: sum of 2 quarters · filed 2021-05-07 | $909.00K derived: sum of 3 quarters · filed 2021-05-07 | $1.21M derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $604.00K derived: sum of 2 quarters · filed 2021-03-12 | $905.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.21M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $602.00K derived: sum of 2 quarters · filed 2020-11-06 | $905.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $604.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $303.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |